RNA sequencing of High Grade Serous Ovarian cancer
RNA-seq (gene expression) · human · 168 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Ovarian cancerThis series is part of our curated briefing on it.
- Samples
- 168 samples: 139 × Brescia Ovarian Tumou vs 29 × Ovarian Tumour Epithelial cellsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment DecisionsClinical cancer research : an official journal of the American Association for Cancer Research · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE291288_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1232721 and SRA study SRP568454. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 168 samples.
How we read this: 2 replicated groups read from 168 sample titles; they account for 168 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8832837 Brescia Ovarian Tumour - 1 Brescia Ovarian Tumou
- GSM8832838 Brescia Ovarian Tumour - 2 Brescia Ovarian Tumou
- GSM8832839 Brescia Ovarian Tumour - 3 Brescia Ovarian Tumou
- GSM8832840 Brescia Ovarian Tumour - 4 Brescia Ovarian Tumou
- GSM8832841 Brescia Ovarian Tumour - 5 Brescia Ovarian Tumou
- GSM8832842 Brescia Ovarian Tumour - 6 Brescia Ovarian Tumou
- GSM8832843 Brescia Ovarian Tumour - 7 Brescia Ovarian Tumou
- GSM8832844 Brescia Ovarian Tumour - 8 Brescia Ovarian Tumou
- GSM8832845 Brescia Ovarian Tumour - 9 Brescia Ovarian Tumou
- GSM8832846 Brescia Ovarian Tumour - 10 Brescia Ovarian Tumou
- GSM8832847 Brescia Ovarian Tumour - 11 Brescia Ovarian Tumou
- GSM8832848 Brescia Ovarian Tumour - 12 Brescia Ovarian Tumou
- GSM8832849 Brescia Ovarian Tumour - 13 Brescia Ovarian Tumou
- GSM8832850 Brescia Ovarian Tumour - 14 Brescia Ovarian Tumou
- GSM8832851 Brescia Ovarian Tumour - 15 Brescia Ovarian Tumou
- GSM8832852 Brescia Ovarian Tumour - 16 Brescia Ovarian Tumou
- GSM8832853 Brescia Ovarian Tumour - 17 Brescia Ovarian Tumou
- GSM8832854 Brescia Ovarian Tumour - 18 Brescia Ovarian Tumou
- GSM8832855 Brescia Ovarian Tumour - 19 Brescia Ovarian Tumou
- GSM8832856 Brescia Ovarian Tumour - 20 Brescia Ovarian Tumou
- GSM8832857 Brescia Ovarian Tumour - 21 Brescia Ovarian Tumou
- GSM8832858 Brescia Ovarian Tumour - 22 Brescia Ovarian Tumou
- GSM8832859 Brescia Ovarian Tumour - 23 Brescia Ovarian Tumou
- GSM8832860 Brescia Ovarian Tumour - 24 Brescia Ovarian Tumou
- GSM8832861 Brescia Ovarian Tumour - 25 Brescia Ovarian Tumou
- GSM8832862 Brescia Ovarian Tumour - 26 Brescia Ovarian Tumou
- GSM8832863 Brescia Ovarian Tumour - 27 Brescia Ovarian Tumou
- GSM8832864 Brescia Ovarian Tumour - 28 Brescia Ovarian Tumou
- GSM8832865 Brescia Ovarian Tumour - 29 Brescia Ovarian Tumou
- GSM8832866 Brescia Ovarian Tumour - 30 Brescia Ovarian Tumou
- GSM8832867 Brescia Ovarian Tumour - 31 Brescia Ovarian Tumou
- GSM8832868 Brescia Ovarian Tumour - 32 Brescia Ovarian Tumou
- GSM8832869 Brescia Ovarian Tumour - 33 Brescia Ovarian Tumou
- GSM8832870 Brescia Ovarian Tumour - 34 Brescia Ovarian Tumou
- GSM8832871 Brescia Ovarian Tumour - 35 Brescia Ovarian Tumou
- GSM8832872 Brescia Ovarian Tumour - 36 Brescia Ovarian Tumou
- GSM8832873 Brescia Ovarian Tumour - 37 Brescia Ovarian Tumou
- GSM8832874 Brescia Ovarian Tumour - 38 Brescia Ovarian Tumou
- GSM8832875 Brescia Ovarian Tumour - 39 Brescia Ovarian Tumou
- GSM8832876 Brescia Ovarian Tumour - 40 Brescia Ovarian Tumou
+ 128 more — browse all 168 samples with per-sample file links →
- GSE268514 Integrative genomic analysis of Korean high-grade serous ovarian cancer 161 samples same disease briefing · shares ovarian, serous, grade
- GSE154600 Multi-omic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma 5 samples same disease briefing · shares ovarian, serous, grade
- GSE57477 Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes 72 samples same disease briefing · shares ovarian, serous
- GSE311212 Transcriptomic profiling in human ovarian cancer cell line OVCAR-3 following CDK2 inhibitor treatment 6 samples same disease briefing · shares ovarian
- GSE128098 TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target 4 samples same disease briefing · shares ovarian
- GSE107251 Hypoxia-inducible factor-1α promotes cell survival during ammonia stress response in ovarian cancer stem-like cells 15 samples same disease briefing · shares ovarian
- GSE314300 Rb CUT&RUN profiling in ovarian cancer cell lines following CDK2 inhibitor treatment 10 samples same disease briefing · shares ovarian
- GSE135242 Hi-C identifies structural variation associated with resistance in paired patient-derived ovarian cancer models 8 samples same disease briefing · shares ovarian
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.